GlassScriptPhysician profile
Steven R Schopick
NPI 1205816998
$33,516.69
in general payments reported to CMS, 2019-2025
13 companies · $1,599 in 2025
The $1,599 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $156 · 2021: $1,352 · 2022: $8,034 · 2023: $4,874 · 2024: $17K · 2025: $1,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $7,579 · Food and Beverage: $5,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,200.00 |
| Travel and Lodging | $7,579.26 |
| Food and Beverage | $5,426.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,381.43 | 2022-2025 | Mazor X System, O-Arm, Catalyft Pl Expandable Interbody System |
| Stryker Corporation | $2,319.16 | 2021-2022 | |
| Life Spine, INC. | $2,119.66 | 2019-2024 | Trulift, Prolift, Prolift Micro |
| Nuvasive, INC. | $1,443.36 | 2019-2023 | Alif, Xlif, Modulus |
| Globus Medical, INC. | $1,411.25 | 2022-2025 | Xlif, Alif, Elsa |
| Aesculap Implant Systems, LLC | $1,067.23 | 2021 | |
| Spine Wave, INC. | $325.81 | 2019-2023 | Annex Adjacent Level System |
| Depuy Synthes Sales INC. | $148.68 | 2019 | |
| Abbott Laboratories | $147.85 | 2019-2021 | |
| Medacta USA, INC. | $72.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $45.85 | 2020 | |
| Lifenet Health | $17.32 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schopick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.